Delivery Order SPE2DB22D3501-SPE2DB25FXC63
Award Date 9/2/25
Potential Completion Date 9/23/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp was awarded a $1,687.48 delivery order (Contract No. 4569266632) by the Defense Logistics Agency on August 27, 2025, for ProQuad vials with an ultimate completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,055.26 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of ProQuad vials. The contract features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by September 23, 2025, at the vendor's Conshohocken facility. This delivery order operates as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 29, 2025, for ProQuad vials with a ceiling value of $50,127. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The delivery order is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This award falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,271.65 for ProQuad vials under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was issued on August 25, 2025, with an ultimate completion date of September 16, 2025. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, critical for military medical readiness and personnel immunization programs. This non-competitive delivery order was placed against...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,874.40 by the Defense Logistics Agency on August 11, 2025, for the supply of ProQuad vials with an ultimate completion date of September 2, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $3,308.68 delivery order from the Defense Logistics Agency (DLA) for ProQuad vials, a combination vaccine product. Awarded on August 29, 2025, with a completion date of September 22, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The award is classified as a child contract, indicating it falls under a larger vehicle—specifically the company's Indefinite...